• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[佝偻病/骨软化症的病理生理学]

[Pathophysiology in rickets/osteomalacia].

作者信息

Takeuchi Yasuhiro

机构信息

Toranomon Hospital Endocrine Center.

出版信息

Clin Calcium. 2007 Oct;17(10):1508-13.

PMID:17906401
Abstract

Rickets/osteomalacia is a disorder causing mineralization defect and bone and skeletal fragility, although production of bone matrix proteins and their architecture is not impaired. The disease is called rickets and osteomalacia in children during skeletal development and in adults, respectively. Pathophysiology in rickets/osteomalacia is defect in vitamin D actions and/or hypophosphatemia. Vitamin D deficiency, inability of activation of vitamin D in vivo or functional derangement in vitamin D receptor is involved in impaired actions of vitamin D. Common causes of hypophosphatemia are excessive actions of fibroblast growth factor (FGF) 23 and renal tubular dysfunction. Among them FGF23 could be a principal regulator for phosphate metabolism, and many investigators are engaged in exploration of physiological and pathophysiological roles of FGF23 in human.

摘要

佝偻病/骨软化症是一种导致矿化缺陷以及骨骼脆弱的病症,尽管骨基质蛋白的产生及其结构并未受损。在骨骼发育阶段的儿童中,该疾病被称为佝偻病,在成年人中则被称为骨软化症。佝偻病/骨软化症的病理生理学特征是维生素D作用缺陷和/或低磷血症。维生素D缺乏、体内维生素D激活能力不足或维生素D受体功能紊乱均与维生素D作用受损有关。低磷血症的常见原因是成纤维细胞生长因子(FGF)23作用过度和肾小管功能障碍。其中,FGF23可能是磷酸盐代谢的主要调节因子,许多研究人员都在探索FGF23在人体中的生理和病理生理作用。

相似文献

1
[Pathophysiology in rickets/osteomalacia].[佝偻病/骨软化症的病理生理学]
Clin Calcium. 2007 Oct;17(10):1508-13.
2
FGF23 and Bone and Mineral Metabolism.成纤维细胞生长因子23与骨和矿物质代谢
Handb Exp Pharmacol. 2020;262:281-308. doi: 10.1007/164_2019_330.
3
The pathophysiology of hypophosphatemia.低磷血症的病理生理学。
Best Pract Res Clin Endocrinol Metab. 2024 Mar;38(2):101851. doi: 10.1016/j.beem.2023.101851. Epub 2023 Nov 30.
4
Physiological regulation and disorders of phosphate metabolism--pivotal role of fibroblast growth factor 23.磷代谢的生理调节与紊乱——成纤维细胞生长因子23的关键作用
Intern Med. 2008;47(5):337-43. doi: 10.2169/internalmedicine.47.0730. Epub 2008 Mar 3.
5
Osteocyte regulation of phosphate homeostasis and bone mineralization underlies the pathophysiology of the heritable disorders of rickets and osteomalacia.成骨细胞调节磷酸盐稳态和矿化作用是遗传性佝偻病和骨软化症病理生理学的基础。
Bone. 2013 Jun;54(2):213-21. doi: 10.1016/j.bone.2013.01.046. Epub 2013 Feb 9.
6
FGF23-FGF Receptor/Klotho Pathway as a New Drug Target for Disorders of Bone and Mineral Metabolism.成纤维细胞生长因子23-成纤维细胞生长因子受体/α-klotho通路作为骨与矿物质代谢紊乱的新药物靶点
Calcif Tissue Int. 2016 Apr;98(4):334-40. doi: 10.1007/s00223-015-0029-y. Epub 2015 Jul 1.
7
[FGF23-related hypophosphatemic rickets/osteomalacia].[成纤维细胞生长因子23相关性低磷性佝偻病/骨软化症]
Clin Calcium. 2007 Oct;17(10):1514-20.
8
[Rickets/Osteomalacia. Action of FGF23.].
Clin Calcium. 2018;28(10):1335-1342.
9
[Fibroblast growth factor (FGF) 23 works as a phosphate-regulating hormone and is involved in the pathogenesis of several disorders of phosphate metabolism].成纤维细胞生长因子(FGF)23作为一种磷酸盐调节激素,参与多种磷酸盐代谢紊乱的发病机制。
Rinsho Byori. 2007 Jun;55(6):555-9.
10
Fibroblast growth factor 23 and its receptors.成纤维细胞生长因子23及其受体。
Ther Apher Dial. 2005 Aug;9(4):308-12. doi: 10.1111/j.1744-9987.2005.00287.x.